Carmell Therapeutics Corporation - Current Ratio

The Current Ratio as of September 2026 (TTM) for Carmell Therapeutics Corporation (CTCX) is 0.07

According to Carmell Therapeutics Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 0.07. This represents a change of -66.56% compared to the average of 0.22 of the last 4 quarters.

Carmell Therapeutics Corporation (CTCX) Historical Current Ratio (quarterly & annually)

How has CTCX Current Ratio performed in the past?

The mean historical Current Ratio of Carmell Therapeutics Corporation over the last ten years is 0.43. The current 0.07 Current Ratio has changed 1.64% with respect to the historical average. Over the past ten years (40 quarters), CTCX's Current Ratio was at its highest in in the September 2021 quarter at 9.47. The Current Ratio was at its lowest in in the March 2021 quarter at 0.

Carmell Therapeutics Corporation (CTCX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Carmell Therapeutics Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Carmell Therapeutics Corporation (CTCX) Average Current Ratio

How has CTCX Current Ratio performed in the past?

The current Current Ratio of Carmell Therapeutics Corporation (CTCX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Carmell Therapeutics Corporation (CTCX) Current Ratio vs. Peers

How is CTCX’s Current Ratio compared to its peers?

Carmell Therapeutics Corporation’s Current Ratio is less than Tricida, Inc. (4.94), less than Entero Therapeutics, Inc. (0.16), less than Tectonic Therapeutic, Inc. (22.29), less than Fresh Tracks Therapeutics, Inc. (6.98), less than Xenetic Biosciences, Inc. (7.43), less than Neuphoria Therapeutics Inc. (27.85), less than BiondVax Pharmaceuticals Ltd. (6.15), less than Kineta, Inc. (0.08), less than Nabriva Therapeutics plc (1.13), less than ModivCare Inc. (1.64),

Build a custom stock screener for Carmell Therapeutics Corporation (CTCX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Carmell Therapeutics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Carmell Therapeutics Corporation (CTCX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Carmell Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.